Linguistic Validation & Independent Translation Review
Regulator-ready evidence that your clinical outcome assessment (COA) is understood, relevant and conceptually equivalent in every target language and population — from full linguistic validation of PRO, ClinRO, ObsRO and PerfO instruments to independent translation review for clinical trials, pharmacovigilance and regulatory submissions.
Request a scope assessment| Guidance | ISPOR · FDA PFDD · EMA |
| Regulators | EMA, FDA, MHRA |
| Turnaround | Scoped per project |
| Delivered from | London, UK |
Understanding the difference
These are related but distinct processes. Knowing which applies to your document type ensures you receive the right service — and the right documentation for your submission.
| Linguistic Validation (LV) | Independent Translation Review (ITR) |
|---|---|
For COA & PRO instruments. A structured, multi-step process — following ISPOR good practice and expected by EMA and FDA — that ensures each translated instrument is conceptually equivalent to the source and understood as intended by patients, caregivers and clinicians in the target population, supporting content validity in every new language and culture. Involves multiple independent linguists and cognitive debriefing with target-population participants.
|
For clinical & regulatory documents. A rigorous back-translation and bilingual review process performed by a specialist linguist with no prior involvement in the translation. Every ITR project includes a formal written review report and a signed Certificate of Translation Quality.
|
When to engage us
Linguistic validation becomes essential whenever a COA is used outside the language, population or mode of administration in which it was first developed. Sponsors and CROs typically come to us when:
- A COA is being introduced in a new country, language or cultural context
- A study is extending to a new age group (for example, paediatric) or a new disease area
- A paper instrument is moving to eCOA/ePRO and translated versions must remain equivalent
- A regulator, ethics committee or sponsor requests evidence of comprehension and relevance
- A rare or hard-to-reach population needs a small, proportionate cognitive debriefing design
We scope the level of evidence to your development stage and regulatory strategy — proportionate, defensible and fit for purpose.
New to the topic? Read our full guide: What is linguistic validation?
Designed for regulated environments
Our clients operate in highly regulated contexts where translation errors carry real consequence — regulatory, clinical, or legal.
| Pharma & biotech | Companies preparing multilingual regulatory submissions to the EMA or MHRA. |
| CROs | Managing multilingual clinical trials requiring validated patient-facing or site-facing materials. |
| Regulatory affairs teams | Requiring documented evidence of translation quality for submission packages. |
| MT-assisted workflows | Organisations using machine translation or post-edited MT who require independent human review and certification. |
| Medical device manufacturers | Requiring translation validation under EU MDR / IVDR. |
Document types we cover
| Document type | Service | Includes |
|---|---|---|
| COA & PRO instruments | LV | PRO instruments, eCOA/ePRO, ClinRO, ObsRO, HRQoL measures. Cognitive debriefing coordination available. |
| Safety & AE documentation | ITR | Adverse event narratives, ICSRs, PSURs, Risk Management Plans. |
| Trial & study materials | ITR | Informed consent forms, patient information sheets, CSRs, protocol amendments. |
| Regulatory submissions | ITR | CTD modules, SmPC, package leaflets, labelling and instructions for use. |
Our process
The steps below apply to both LV and ITR projects. For full LV, cognitive debriefing (Step 4) is included. For ITR, the process concludes at Step 5 with a Certificate of Translation Quality.
- Scope assessmentWe review the source document, target language, intended use, and applicable regulatory framework — and confirm whether LV or ITR is the appropriate service.
- Independent specialist assignmentA subject-matter specialist linguist is assigned with no prior involvement in the translation.
- Back-translation & bilingual reviewA blind back-translation is produced and reconciled against the source. For LV projects, forward translation and reconciliation precede this step per ISPOR methodology.
- Cognitive debriefingLV onlyNative-speaking participants from the target population — patients and, where relevant, caregivers — are interviewed to confirm that items, instructions and response options are understood, relevant and acceptable. Sample sizes are fit for purpose, with lean designs for rare-disease and paediatric studies. Interviews are led by our LV partners at GRC Health.
- Formal review reportA regulator-ready report documenting item-level findings, issues identified and resolutions applied, with clear recommendations and confirmation of suitability for intended use. If an item doesn’t work in the target culture, the report says so and proposes revisions.
- Signed certificateA Certificate of Validation (LV) or Certificate of Translation Quality (ITR) is issued — ready for your EMA, MHRA, or internal QA submission package.
Working with the best in the field
TIL's certified linguistic infrastructure operates within the broader LV process. For full LV studies, we work alongside specialist partners who lead methodology, cognitive debriefing design, and regulatory reporting.
GRC Health (Gibson Research Consultancy)
CRO · Leeds, UK · Global reach
GRC Health is a Leeds-based contract research organisation led by CEO Mark Gibson, with decades of experience in clinical research and linguistic validation methodology. GRC brings the regulatory and scientific expertise that underpins every full LV study TIL supports.
Together, TIL and GRC Health offer a complete, end-to-end solution — specialist LV methodology led by experienced consultants, supported by TIL's certified, human-only linguist network across 220+ languages.
Why TranslationsInLondon
| ITI Corporate MembersSubject to the ITI Code of Professional Conduct. Verifiable via the ITI directory. | ISO 17100 alignedOur quality management processes follow ISO 17100 requirements. |
| Human only — no MTNo machine translation at any stage. Every validator is a qualified specialist. | Genuine independenceValidators are never the same person as the translator. |
| Formal documentationWritten review report and signed certificate issued for every project. | London-basedAvailable for client audits, regulatory team calls, and in-person meetings. |
| Psychometric integrity protectedTranslations preserve the measurement properties of the original instrument, so scores remain comparable across countries. | Fit-for-purpose evidenceProportionate, defensible study designs matched to your development stage and regulatory strategy. |
Frequently asked questions
How many participants do we need for cognitive debriefing?
There is no fixed number. ISPOR and FDA guidance call for fit-for-purpose samples, typically 5–8 participants per language. Our standard package covers 5 participants per country, with leaner designs for rare or hard-to-reach populations.
Do we need to involve the instrument developer?
Usually, yes. Most COAs are copyrighted and developers often need to approve translations. We can liaise with them on your behalf.
Can linguistic validation replace psychometric validation?
No. Linguistic validation supports content validity and conceptual equivalence; psychometric validation requires a separate quantitative study.
Can the report be used in regulatory submissions?
Yes. Our LV reports are designed for inclusion in submission packages for EMA, FDA and MHRA.
You may also need
Request a scope assessment
LV is quoted per project following scope assessment. ITR is quoted per word or per hour depending on document type and volume.
Get in touch